يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Luisa Latargia, M"', وقت الاستعلام: 0.33s تنقيح النتائج
  1. 1
    Electronic Resource
    REL-Protocol PhilosoPhi34: An Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia Patients, to Study the Disappearance of CD34+/Lin-Ph+ Cells from Bone Marrow during Treatment. Preliminary Data

    المؤلفون: Pungolino, E, Rossi, G, Angela Mura, M, Perego, A, Maria Orlandi, E, Turrini, M, Borin, L, Adele Capucci, M, Iurlo, A, Trojani, A, D'Adda, M, Spina, F, De Canal, G, Luisa Pioltelli, M, Luisa Latargia, M, Pauli, S, Elena, C, Brusorio, S, Lanza, F, Malato, S, Anghilieri, M, C Carraro, M, Morra, E, Cairoli, R, Ester Pungolino, Giuseppe Rossi, Maria Angela Mura, Alessandra Perego, Ester Maria Orlandi, Mauro Turrini, Lorenza Borin, Maria Adele Capucci, Alessandra Iurlo, Alessandra Trojani, Mariella D'Adda, Francesco Spina, Gabriella De Canal, Maria Luisa Pioltelli, Maria Luisa Latargia, Sergio Pauli, Chiara Elena, Stefania Brusorio, Francesco Lanza, Simona Malato, Michela Anghilieri, Maria C Carraro, Enrica Morra, Roberto Cairoli

    مصطلحات الفهرس: hematology, info:eu-repo/semantics/conferenceObject

    URL: https://hdl.handle.net/10281/410615
    info:eu-repo/semantics/altIdentifier/wos/WOS:000368019005075
    57th Annual Meeting of the American-Society-of-Hematology - DEC 05-08, 2015
    volume:126
    issue:23
    journal:BLOOD

    View record in OAIster

    أضف إلى المفضلة
  2. 2
    Conference
    REL-Protocol PhilosoPhi34: An Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia Patients, to Study the Disappearance of CD34+/Lin-Ph+ Cells from Bone Marrow during Treatment. Preliminary Data

    المؤلفون: Ester Pungolino, Giuseppe Rossi, Maria Angela Mura, Alessandra Perego, Ester Maria Orlandi, Mauro Turrini, Lorenza Borin, Maria Adele Capucci, Alessandra Iurlo, Alessandra Trojani, Mariella D'Adda, Francesco Spina, Gabriella De Canal, Maria Luisa Pioltelli, Maria Luisa Latargia, Sergio Pauli, Chiara Elena, Stefania Brusorio, Francesco Lanza, Simona Malato, Michela Anghilieri, Maria C Carraro, Enrica Morra, Roberto Cairoli

    المساهمون: Pungolino, E, Rossi, G, Angela Mura, M, Perego, A, Maria Orlandi, E, Turrini, M, Borin, L, Adele Capucci, M, Iurlo, A, Trojani, A, D'Adda, M, Spina, F, De Canal, G, Luisa Pioltelli, M, Luisa Latargia, M, Pauli, S, Elena, C, Brusorio, S, Lanza, F, Malato, S, Anghilieri, M, C Carraro, M, Morra, E, Cairoli, R

    مصطلحات موضوعية: hematology

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000368019005075; 57th Annual Meeting of the American-Society-of-Hematology - DEC 05-08, 2015; volume:126; issue:23; journal:BLOOD; https://hdl.handle.net/10281/410615

    الاتاحة: https://hdl.handle.net/10281/410615
    https://doi.org/10.1182/blood.V126.23.1597.1597

    View record in BASE

    أضف إلى المفضلة
  3. 3
    REL-Protocol PhilosoPhi34: An Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia Patients, to Study the Disappearance of CD34+/Lin-Ph+ Cells from Bone Marrow during Treatment. Preliminary Data

    المؤلفون: Giuseppe Rossi, Simona Malato, Gabriella De Canal, Alessandra Perego, Alessandra Iurlo, Ester Pungolino, Ester Orlandi, Alessandra Trojani, Maria Luisa Latargia, S Pauli, Mauro Turrini, Mariella D'Adda, Chiara Elena, Francesco Lanza, Lorenza Borin, Enrica Morra, Francesco Spina, Roberto Cairoli, Maria Luisa Pioltelli, Stefania Brusorio, Michela Anghilieri, Maria Cristina Carraro, Maria Adele Capucci, Maria Angela Mura

    المساهمون: Pungolino, E, Rossi, G, Angela Mura, M, Perego, A, Maria Orlandi, E, Turrini, M, Borin, L, Adele Capucci, M, Iurlo, A, Trojani, A, D'Adda, M, Spina, F, De Canal, G, Luisa Pioltelli, M, Luisa Latargia, M, Pauli, S, Elena, C, Brusorio, S, Lanza, F, Malato, S, Anghilieri, M, C Carraro, M, Morra, E, Cairoli, R

    مصطلحات موضوعية: medicine.medical_specialty, Pathology, business.industry, hematology, Immunology, CD34, Phases of clinical research, Cell Biology, Biochemistry, Gastroenterology, medicine.anatomical_structure, Imatinib mesylate, Nilotinib, Internal medicine, Medicine, Bone marrow, Stem cell, Progenitor cell, business, Sokal Score, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aedaa2995249232aa56666e7c33cc8b4
    https://hdl.handle.net/10281/410615

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء